CEBM Home Page Index to this Site How to use the site Teaching Resources and Activities The CAT Bank About the Book <I>How to Practice and Teach EBM</i> EBM Glossary The EBM ToolBox

CAL (CHRONIC AIRFLOW LIMITATION) EXACERBATIONS (OF DYSPNEA, COUGH, AND SPUTOM) BENEFIT FROM ANTIBIOTICS

Clinical Bottom Line(s):

As soon as CAL patients develop exacerbations (2 or more of increasing dyspnoea, increased sputum, or purulent sputum), have them start ten days of:

a. trimethoprim (160mg)/sulfamethoxazole (800 mg) twice daily

OR b. amoxycillin (250 mg qid)

OR c. doxycycline (200 mg stat and the 100 mg per day)

and they will be less likely to require hospitalisation or other antibiotics.

 

Appraised by: Sackett, 10 April 1995

 

The Evidence: [1] A 3.5 year RCT of any of three antibiotics (doc’s choice) vs identical placebos in 173 patients with CAL (mean FEV1 = 34% of expected; peak flow 228 L/min), living in and around Winnepeg Canada, who averaged about 0.6 exacerbations per year.

 

endpoints

Control

 

Treated

RRR

ARR

NNT (exacer- bations)

Deteriorated to the point where they needed hospitalisation or additional antibiotic

0.189

(34/180)

0.099

(18/182)

48%

0.09

11

(6-59 )

Number of exacerbations you Need to Treat to prevent one deterioration

 

Comments:

1. Lost a lot of patients along the way (18 died, 15 wouldn’t cooperate, and their docs withdrew an additional 17) ‘tho they didn’t differ from remainder in symptoms or lung function.

Date of expiry: 1 April 1997

 

REFERENCES:

[1] Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.



Click here to comment on this CAT
Go Back to Search